Literature DB >> 17998764

Low serum testosterone concentration in middle-aged men with type 2 diabetes.

Michiaki Fukui1, Jintetsu Soh, Muhei Tanaka, Yoshihiro Kitagawa, Goji Hasegawa, Toshikazu Yoshikawa, Tsuneharu Miki, Naoto Nakamura.   

Abstract

Low concentrations of endogenous androgens have been linked with insulin resistance and atherosclerosis. Men with diabetes have been reported to have lower serum testosterone concentration than non-diabetic men; however, there has never been a large study. The aim of this study was to investigate if endogenous androgen concentration is certainly lower in a relatively large number of Japanese patients with type 2 diabetes compared with healthy men, and to identify what factors may be associated with low serum testosterone concentrations in men with type 2 diabetes. Serum free testosterone concentrations were measured in 524 healthy men and in 331 consecutive Japanese men with type 2 diabetes between 40 and 69 years old. In addition, we investigated the relationships between serum free testosterone concentration and luteinizing hormone (LH) concentration as well as major cardiovascular risk factors including age, blood pressure, plasma lipid concentration, glycemic control (HbA(1c)), and BMI. Serum free testosterone concentrations were lower in men with type 2 diabetes than in healthy men in the 40-49 years group (10.9 +/- 3.3 vs. 14.0 +/- 3.6 pg/ml, P<0.0001), in the 50-59 years group (10.4 +/- 3.2 vs. 12.1 +/- 2.9 pg/ml, P<0.0001), and in the 60-69 years group (9.5 +/- 2.6 vs. 10.5 +/- 2.9 pg/ml, P = 0.0104). A negative correlation was found between serum free testosterone and LH concentrations (r = -0.326, P<0.0001). In conclusion, serum free testosterone concentration is certainly lower in a relatively large number of Japanese patients with type 2 diabetes compared with healthy men with each decade of life between 40 and 69 years old.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17998764     DOI: 10.1507/endocrj.k07-077

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  15 in total

1.  Testosterone stimulates glucose uptake and GLUT4 translocation through LKB1/AMPK signaling in 3T3-L1 adipocytes.

Authors:  Kazuteru Mitsuhashi; Takafumi Senmaru; Takuya Fukuda; Masahiro Yamazaki; Katsuhiko Shinomiya; Morio Ueno; Shigeru Kinoshita; Jo Kitawaki; Masato Katsuyama; Muneo Tsujikawa; Hiroshi Obayashi; Naoto Nakamura; Michiaki Fukui
Journal:  Endocrine       Date:  2015-06-23       Impact factor: 3.633

Review 2.  Sex, diabetes and the kidney.

Authors:  Christine Maric
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

3.  Expression of aromatase, androgen and estrogen receptors in peripheral target tissues in diabetes.

Authors:  Anjali Prabhu; Qin Xu; Michaele B Manigrasso; Moumita Biswas; Elizabeth Flynn; Radu Iliescu; Edwin D Lephart; Christine Maric
Journal:  Steroids       Date:  2010-01-11       Impact factor: 2.668

4.  Association between testosterone, estradiol and sex hormone binding globulin levels in men with type 1 diabetes with nephropathy.

Authors:  Christine Maric; Carol Forsblom; Lena Thorn; Johan Wadén; Per-Henrik Groop
Journal:  Steroids       Date:  2010-01-25       Impact factor: 2.668

Review 5.  Sex-related differences in diabetic kidney disease: A review on the mechanisms and potential therapeutic implications.

Authors:  Federica Piani; Isabella Melena; Kalie L Tommerdahl; Natalie Nokoff; Robert G Nelson; Meda E Pavkov; Daniël H van Raalte; David Z Cherney; Richard J Johnson; Kristen J Nadeau; Petter Bjornstad
Journal:  J Diabetes Complications       Date:  2020-12-31       Impact factor: 2.852

6.  Prevalence of low testosterone levels in men with type 2 diabetes mellitus: a cross-sectional study.

Authors:  Ayman A Al Hayek; Yousef S Khader; Sahar Jafal; Nahla Khawaja; Asirvatham A Robert; Kamel Ajlouni
Journal:  J Family Community Med       Date:  2013-09

7.  Low serum testosterone concentrations in hospitalized men with poorly controlled type 2 diabetes.

Authors:  Kyung Soo Kim; San Ha Kang; Moon Jong Kim; Soo Kyung Kim; Yoo Lee Kim; Won Keun Park; Seok Won Park; Yong Wook Cho
Journal:  Endocrinol Metab (Seoul)       Date:  2014-05-27

8.  Clinical and biochemical correlates of hypogonadism in men with type 2 diabetes mellitus.

Authors:  Ezekiel Musa; Jibril Mohammed El-Bashir; Fatima Sani-Bello; Adamu Girei Bakari
Journal:  Pan Afr Med J       Date:  2021-03-19

9.  Time for international action on treating testosterone deficiency syndrome.

Authors:  Malcolm Carruthers
Journal:  Aging Male       Date:  2009-03       Impact factor: 5.892

10.  Hypogonadism and metabolic syndrome in nigerian male patients with both type 2 diabetes and hypertension.

Authors:  Oluyemi Akinloye; Bolutife Blessing Popoola; Mary Bolanle Ajadi; Joseph Gregory Uchechukwu; Dolapo Pius Oparinde
Journal:  Int J Endocrinol Metab       Date:  2014-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.